3-((3S,5S,8R,9S,10S,13R,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,10,11,12,13,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one

Catalog No. :
ACTNFE386
CAS No. :
3080-20-4
Molecular Formula :
C23H32O3
Molecular Weight :
356.51

IUPAC Name:3-((3S,5S,8R,9S,10S,13R,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,10,11,12,13,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one

3-((3S,5S,8R,9S,10S,13R,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,10,11,12,13,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-((3S,5S,8R,9S,10S,13R,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,10,11,12,13,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one
IUPAC Name3-((3S,5S,8R,9S,10S,13R,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,10,11,12,13,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one
Molecular FormulaC23H32O3
Molecular Weight356.51
SMILESC[C@]12CC[C@H](O)C[C@@H]1CC[C@H]1C3=CC[C@H](C4=CCOC4=O)[C@@]3(C)CC[C@@H]12
InChI KeyDPDKGFZJWHLPLO-UENNAJKTSA-N
Synonymbeta-Anhydrouzarigenin;β-Anhydrouzarigenin;3beta-Hydroxy-5alpha-carda-14,20(22)-dienolide;Carda-14,20(22)-dienolide, 3-hydroxy-, (3β,5α)-;β-Anhydroepidigitoxigenin
CAS No.3080-20-4

Synthetic Route by SureRoute

1. ACTNFE386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTNFE386 route product structure diagram
    ACTNFE3863080-20-4
Inquiry

2. ACTNFE386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTNFE386 route product structure diagram
    ACTNFE3863080-20-4
Inquiry

Comments (0)